A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Clinical trial NCT05367765 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05367765
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-30
- Primary completion
- 2027-04-30
- Enrollment
- 2400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.